Encyclopedia of Signaling Molecules

2018 Edition
| Editors: Sangdun Choi


  • Betsy J. BarnesEmail author
Reference work entry
DOI: https://doi.org/10.1007/978-3-319-67199-4_307


Historical Background

The transcription factor interferon regulatory factor 5 (IRF5) is one of the newer members of the IRF family to be characterized. All cellular family members share a region of homology in the amino-terminus, encompassing a highly conserved DNA binding domain consisting of five tryptophan repeats. By crystallography, this region has been shown to bind to conserved elements, termed “interferon (IFN)-stimulated response elements” (ISREs), in the promoters of target genes (Chen et al. 2008) thereby exerting the biological effects of IRF5. Given the nomenclature of this family, it is not surprising that the first function of IRF5 to be recognized was its ability to regulate type I IFN gene expression (Barnes et al. 2001). However, unlike other IRF family members, such as IRF3 and IRF7, the activity of IRF5 is regulated in a virus-specific manner leading to the induction of distinct IFNA genes (Barnes et al. 2001).

Regulation of...

This is a preview of subscription content, log in to check access.


  1. Barnes BJ, Moore PA, Pitha PM. Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes. J Biol Chem. 2001;276:23382–90.CrossRefPubMedGoogle Scholar
  2. Barnes BJ, Kellum MJ, Field AE, Pitha PM. Multiple regulatory domains of IRF-5 control activation, cellular localization and induction of chemokines that mediate T-lymphocyte recruitment. Mol Cell Biol. 2002;22:5721–40.PubMedPubMedCentralCrossRefGoogle Scholar
  3. Barnes BJ, Kellum MJ, Pinder KE, Frisancho JA, Pitha PM. IRF-5, a novel mediator of cell-cycle arrest and cell death. Cancer Res. 2003;63:6424–31.PubMedGoogle Scholar
  4. Barnes BJ, Richards J, Mancl M, Hanash S, Beretta L, Pitha PM. Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection. J Biol Chem. 2004;279:45194–207.CrossRefPubMedGoogle Scholar
  5. Chen W, Lam SS, Srinath H, Jiang Z, Correia JJ, Schiffer CA, et al. Insights into interferon regulatory factor activation from the crystal structure of dimeric IRF5. Nat Struct Mol Biol. 2008;15:1213–20.PubMedPubMedCentralCrossRefGoogle Scholar
  6. Cheng TF, Brzostek S, Ando O, Van Scoy S, Kumar KP, Reich NC. Differential activation of IFN regulatory factor (IRF)-3 and IRF-5 transcription factors during viral infection. J Immunol. 2006;176:7462–70.CrossRefPubMedGoogle Scholar
  7. Couzinet A, Tamura K, Chen HM, Nishimura K, Wang Z, Morishita Y, et al. A cell-type-specific requirement for IFN regulatory factor 5 (IRF5) in Fas-induced apoptosis. Proc Natl Acad Sci USA. 2008;105:2556–61.PubMedPubMedCentralCrossRefGoogle Scholar
  8. Feng D, Stone RC, Elonranta ML, Sangster-Guity N, Singh S, Nordmark G, et al. Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus. Arthritis Rheum. 2010;62:562–73.PubMedPubMedCentralGoogle Scholar
  9. Hu G, Barnes BJ. IRF-5 is a mediator of the death receptor-induced apoptotic signaling pathway. J Biol Chem. 2009;284:2767–77.CrossRefPubMedGoogle Scholar
  10. Hu G, Mancl ME, Barnes BJ. Signaling through interferon regulatory factor-5 sensitizes p53-deficient tumor to DNA damage-induced apoptosis and cell death. Cancer Res. 2005;65:7403–12.CrossRefPubMedGoogle Scholar
  11. Kozyrev SV, Alarcon-Riquelme ME. The genetics and biology of Irf5-mediated signaling in lupus. Autoimmunity. 2007;40:591–601.CrossRefPubMedGoogle Scholar
  12. Krausgruber T, Saliba D, Ryzhakov G, Lanfrancotti A, Blazek K, Udalova IA. IRFS is required for late-phase TNF secretion by human dendritic cells. Blood. 2010;115:4421–30.CrossRefPubMedGoogle Scholar
  13. Mancl ME, Hu G, Sangster-Guity N, Olshalsky SL, Hoops K, Fitzgerald-Bocarsly P, et al. Two distinct promoters regulate the alternative-spliced human Interferon regulatory factor-5 variants: multiple variants with distinct cell-type specific expression, localization, regulation and function. J Biol Chem. 2005;280:21078–90.CrossRefPubMedGoogle Scholar
  14. Mori T, Anazawa Y, Iiizumi M, Fukuda S, Nakamura Y, Arakawa H. Identification of the interferon regulatory factor 5 gene (IRF-5) as a direct target for p53. Oncogene. 2002;21:2914–8.CrossRefPubMedGoogle Scholar
  15. Niewold TB, Kelly JA, Flesch MH, Espinoza LR, Harley JB, Crow MK. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients. Arthritis Rheum. 2008;58:2481–7.PubMedPubMedCentralCrossRefGoogle Scholar
  16. Paun A, Reinert JT, Jiang Z, Medin C, Balkhi MY, Fitzgerald KA, Pitha PM. Functional charcterization of murine interferon regulatory factor 5(IRF-5) and its role in the innate antiviral response. J Biol Chem. 2008;283:14295–308.PubMedPubMedCentralCrossRefGoogle Scholar
  17. Richez C, Yasuda K, Bonegio RG, Watkins AA, Aprahamian T, Busto P, et al. IFN regulatory factor 5 is required for disease development in the FcgammaRIIB−/−Yaa and FcgammaRIIB−/− mouse models of systemic lupus erythematosus. J Immunol. 2010;184:796–806.CrossRefPubMedGoogle Scholar
  18. Savitsky DA, Yanai H, Tamura T, Taniguchi T, Honda K. Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus. Proc Natl Acad Sci USA. 2010;107:10154–9.PubMedPubMedCentralCrossRefGoogle Scholar
  19. Schoenemeyer A, Barnes BJ, Mancl ME, Latz E, Goutagny N, Pitha PM, et al. The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling. J Biol Chem. 2005;280:17005–12.CrossRefPubMedGoogle Scholar
  20. Shin SH, Kim BH, Jang JJ, Suh KS, Kang GH. Identification of novel methylation markers in hepatocellular carcinoma using a methylation array. J Korean Med Sci. 2010;25:1152–9.PubMedPubMedCentralCrossRefGoogle Scholar
  21. Takaoka A, Yanai H, Kondo S, Duncan G, Negishi H, Mizutani T, et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature. 2005;434:243–9.CrossRefPubMedGoogle Scholar
  22. Yanai H, Chen HM, Inuzuka T, Kondo S, Mak TW, Takaoka A, et al. Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression. Proc Natl Acad Sci USA. 2007;104:3402–7.PubMedPubMedCentralCrossRefGoogle Scholar
  23. Yasuda K, Richez C, Maciaszek JW, Agrawal N, Akira S, Marshak-Rothstein A, et al. Murine dendritic cell type I IFN production induced by human IgG-RNA immune complexes is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 production. J Immunol. 2007;178:6876–85.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of Biochemistry and Molecular BiologyNew Jersey Medical School-University Hospital Cancer Center, University of Medicine and Dentistry of New JerseyNewarkUSA